Search Results 201-210 of 16734 for Clenpiq

  1. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  2. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...

  3. Pegfilgrastim-pbbk (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Pegfilgrastim-pbbk injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  4. Neurology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  5. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

    Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...

  6. A Study To Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed And/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - Mayo Clinic

    The goal of this study is to compare how well sonrotoclax plus obinutuzumab works versus venetoclax plus rituximab in treating adults with relapsed and/or ...

  7. Gastroenterology and Hepatology - Clinical trials

    One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...

  8. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...

  9. Oncology (Medical) - Clinical trials

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  10. Aflibercept-yszy (intraocular route) - Side effects & uses - Mayo Clinic

    Aflibercept-yszy injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes ...